Sex Hormone-Binding Globulin in the Diagnosis of Peripheral Tissue Resistance to Thyroid Hormone: The Value of Changes after Short Term Triiodothyronine Administration*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Thyroid hormone is one of several factors that modulate the level of sex hormone-binding globulin (SHBG) in serum. SHBG levels are usually elevated in thyrotoxicosis and have been reported to be normal in a few patients with generalized resistance to thyroid hormone (GRTH). This study was designed to determine whether basal serum SHBG levels or the SHBG response to short term T3 administration could be used as an index of thyroid hormone action and thus serve as a test for the evaluation of patients suspected of having peripheral tissue resistance to thyroid hormone. Serum SHBG, total T4, free T4 index (FT4I), total T3, and TSH levels were measured in 21 normal subjects, 28 hypothyroid patients, 20 thyrotoxic patients, and 10 patients with GRTH. Excluding patients with GRTH, serum basal SHBG values were correlated with FT4I values (r = 0.66; P < 0.0001). Mean SHBG levels in the patients with GRTH [37.6 ± 16.2 (±sd) nmol/L] were not significantly different from those in the normal subjects (35.1 ± 19.3 nmol/L) or hypothyroid patients (26.3 ± 17.1 nmol/L), but were significantly lower than those in the thyrotoxic group (64.7 ± 19.2 nmol/L; P < 0.001). All 10 patients with GRTH had basal SHBG values in the normal range, but 7 of 20 (35%) thyrotoxic patients also had normal basal SHBG values. T3 was given orally for three sequential 3-day periods at doses of 50,100, and 200 μg daily to 7 normal subjects, 11 hypothyroid and 3 thyrotoxic patients, and all 10 patients with GRTH. The serum SHBG concentration was measured on the last day at each dosage level. During T3 administration, SHBG levels increased in all individuals with normal tissue responsiveness. The increase above the basal value (ΔSHBG) at each T3 dose was similar in normal, hypothyroid, and thyrotoxic individuals (nonresistant subjects). After administration of 50 ng T3 daily, the mean ΔSHBG level was decreased [−2.9 ± 5.3 (±SD) nmol/L] in the resistant patients and increased (4.0 ± 4.9 nmol/L; P < 0.005) in the nonresistant subjects. After administration of 100 μg T3 daily, the mean ASHBG was −4.5 ± 6.8 nmol/L in the resistant patients and 8.6 ± 5.1 nmol/L (P < 0.0001) in the nonresistant subjects. Serum SHBG decreased by more than 2 nmol/L in 6 of 10 (60%) resistant patients, but in no nonresistant subject. After administration of 200 μg T3 daily, the mean ΔSHBG increase was 0.7 ± 7.3 nmol/L in the resistant patients and 16.6 ± 7.3 nmol/L (P < 0.0001) in the nonresistant subjects. Neither the combination of a normal basal serum SHBG value and elevated serum thyroid hormone values nor the relationship between serum SHBG and FT4I values was sufficient t o separate all GRTH patients from those with thyrotoxicosis. The combination of elevated serum thyroid hormone values and failure of serum SHBG to increase above the basal value after the administration of T3 for 6 days was found in 9 of 10 patients with GRTH but in none of the thyrotoxic subjects. The response of SHBG to T3 administration is useful in the demonstration of peripheral tissue resistance to thyroid hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Induced Hyperthyroidism on Steroid Metabolism in Man
RUDER, H., CORVOL, P., MAHOUDEAU, J. A., ROSS, G. T., & LIPSETT, M. B. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-3-382 · Cited by 139
Cited by
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482
Multicenter Study on the Prevalence of Sexual Symptoms in Male Hypo- and Hyperthyroid Patients
Carani, C., Isidori, A. M., Granata, A., Carosa, E., Maggi, M., Lenzi, A., & Jannini, E. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1135 · Cited by 416
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
Thyroid Hormone and Male Gonadal Function*
JANNINI, E. A., ULISSE, S., & D'ARMIENTO, M. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-443 · Cited by 308
TSH and thyrotropic agonists: key actors in thyroid homeostasis
Dietrich, J. W., Landgrafe, G., & Fotiadou, E. H. (2012) · Journal of Thyroid Research · doi:10.1155/2012/351864 · Cited by 146
Metadata
- Authors
- SARNE, D. H., REFETOFF, S., ROSENFIELD, R. L., & FARRIAUX, J. P.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1988-04
- Volume
- 66
- Issue
- 4
- Pages
- 740-746
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161200102
- Cited by
- 94
- References
- 1
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sex Hormone-Binding Globulin in the Diagnosis of Peripheral Tissue Resistance to Thyroid Hormone: The Value of Changes after Short Term Triiodothyronine Administration*. https://app.cochat.ai/papers/10.1210/jcem-66-4-740
- The paper
- SARNE, D. H., REFETOFF, S., ROSENFIELD, R. L., & FARRIAUX, J. P. (1988). Sex Hormone-Binding Globulin in the Diagnosis of Peripheral Tissue Resistance to Thyroid Hormone: The Value of Changes after Short Term Triiodothyronine Administration*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-66-4-740
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.